[go: up one dir, main page]

GB201221046D0 - Method of diagnosis - Google Patents

Method of diagnosis

Info

Publication number
GB201221046D0
GB201221046D0 GBGB1221046.4A GB201221046A GB201221046D0 GB 201221046 D0 GB201221046 D0 GB 201221046D0 GB 201221046 A GB201221046 A GB 201221046A GB 201221046 D0 GB201221046 D0 GB 201221046D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1221046.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MENS HEALTH Ltd
Original Assignee
MENS HEALTH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MENS HEALTH Ltd filed Critical MENS HEALTH Ltd
Priority to GBGB1221046.4A priority Critical patent/GB201221046D0/en
Publication of GB201221046D0 publication Critical patent/GB201221046D0/en
Priority to PCT/GB2013/000509 priority patent/WO2014080162A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1221046.4A 2012-11-22 2012-11-22 Method of diagnosis Ceased GB201221046D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1221046.4A GB201221046D0 (en) 2012-11-22 2012-11-22 Method of diagnosis
PCT/GB2013/000509 WO2014080162A1 (en) 2012-11-22 2013-11-21 Vip and an alpha-adrenergic blocker for use in the diagnosis of erectile dysfunction and vascular ischaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1221046.4A GB201221046D0 (en) 2012-11-22 2012-11-22 Method of diagnosis

Publications (1)

Publication Number Publication Date
GB201221046D0 true GB201221046D0 (en) 2013-01-09

Family

ID=47560513

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1221046.4A Ceased GB201221046D0 (en) 2012-11-22 2012-11-22 Method of diagnosis

Country Status (2)

Country Link
GB (1) GB201221046D0 (en)
WO (1) WO2014080162A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024233903A1 (en) * 2023-05-11 2024-11-14 Wayne State University Combination treatments to promote epithelial integrity and treat ocular disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
US5447912A (en) * 1989-09-18 1995-09-05 Senetek, Plc Erection-inducing methods and compositions
US5236904A (en) * 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions

Also Published As

Publication number Publication date
WO2014080162A1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
PL2825719T3 (en) Method of well operation
ZA201501833B (en) Method for obtaining 1-kestone
GB201212937D0 (en) Method
HUP1200607A2 (en) Diagnostic method
GB201212934D0 (en) Method
GB201213636D0 (en) Method
GB201210858D0 (en) Method
PL2931937T3 (en) Method of producing metal-nanoparticle-arrays
PL2809816T3 (en) Expression method
GB201218570D0 (en) Method
AP2013007084A0 (en) Diagnostic method
GB201218341D0 (en) Diagnostic method
GB201220155D0 (en) Method of manufacture
GB201202198D0 (en) Method
GB201100223D0 (en) Diagnostic method
GB201215942D0 (en) Method of treatent
GB201211393D0 (en) Method
ZA201503833B (en) Method of hemoglobin-f determination
GB201214029D0 (en) method
GB201221046D0 (en) Method of diagnosis
EP2911662A4 (en) Method of treatment of disease
GB201213858D0 (en) Method
GB201203337D0 (en) Method
GB201212279D0 (en) Method of construction
GB201221032D0 (en) Method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)